Anti-NMNAT2 antibody (218-268) (STJA0006540)

SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenSynthesized peptide derived from human NMNA2 AA range: 218-268
STJA0006540
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit polyclonal anti-Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 (218-268) for use in WB in Human, Mouse and Rat samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsWB
HostRabbit
ReactivityHuman/Mouse/Rat
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityPolyclonal
IsotypeIgG
ConjugationUnconjugated
Concentration1 mg/mL
PurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Dilution RangeWB 1:1000-2000
FormulationLiquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Storage InstructionStore at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.

Target Information

Gene SymbolNMNAT2
Gene ID23057
Uniprot IDNMNA2_HUMAN
ImmunogenSynthesized peptide derived from human NMNA2 AA range: 218-268
Immunogen Region218-268
SpecificityThis antibody detects endogenous levels of human NMNA2

Additional Info

Post Translational Modifications Degraded in response to injured neurite. Degradation is caused by polyubiquitination by MYCBP2 after recognition by FBXO45. Palmitoylated.palmitoylation is required for membrane association.
Function Nicotinamide/nicotinate-nucleotide adenylyltransferase that acts as an axon maintenance factor. Axon survival factor required for the maintenance of healthy axons: acts by delaying Wallerian axon degeneration, an evolutionarily conserved process that drives the loss of damaged axons. Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form.nicotinic acid mononucleotide (NaMN) as substrate but with a lower efficiency. Cannot use triazofurin monophosphate (TrMP) as substrate. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+). For the pyrophosphorolytic activity prefers NAD(+), NADH and NaAD as substrates and degrades nicotinic acid adenine dinucleotide phosphate (NHD) less effectively. Fails to cleave phosphorylated dinucleotides NADP(+), NADPH and NaADP(+). Also acts as an activator of ADP-ribosylation by supporting the catalytic activity of PARP16 and promoting mono-ADP-ribosylation of ribosomes by PARP16. May be involved in the maintenance of axonal integrity.
Protein Name Nicotinamide/Nicotinic Acid Mononucleotide Adenylyltransferase 2
Nmn/Namn Adenylyltransferase 2
Nicotinamide Mononucleotide Adenylyltransferase 2
Nmn Adenylyltransferase 2
Nicotinate-Nucleotide Adenylyltransferase 2
Namn Adenylyltransferase 2
Database Links Reactome: R-HSA-196807
Cellular Localisation Golgi Apparatus Membrane
Lipid-Anchor
Cytoplasmic Vesicle Membrane
Cytoplasm
Cell Projection
Axon
Delivered To Axons With Golgi-Derived Cytoplasmic Vesicles
Alternative Antibody Names Anti-Nicotinamide/Nicotinic Acid Mononucleotide Adenylyltransferase 2 antibody
Anti-Nmn/Namn Adenylyltransferase 2 antibody
Anti-Nicotinamide Mononucleotide Adenylyltransferase 2 antibody
Anti-Nmn Adenylyltransferase 2 antibody
Anti-Nicotinate-Nucleotide Adenylyltransferase 2 antibody
Anti-Namn Adenylyltransferase 2 antibody
Anti-NMNAT2 antibody
Anti-C1orf15 antibody
Anti-KIAA0479 antibody

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins